HisGB1-CITED2(216-269)+CBPTAZ1(340-439)
(Plasmid
#173761)
-
PurposeBacterial coexpression of human CITED2 CTAD with CBP TAZ1
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 173761 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepEt22b
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 5500
- Total vector size (bp) 6300
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert 1
-
Gene/Insert nameCITED2 (216-269)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)165
-
Entrez GeneCITED2 (a.k.a. ASD8, MRG-1, MRG1, P35SRJ, VSD2)
- Promoter T7
Cloning Information for Gene/Insert 1
- Cloning method Restriction Enzyme
- 5′ cloning site NdeI (not destroyed)
- 3′ cloning site BamHI (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer T7 (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert nameCBP TAZ1 (340-439)
-
Alt nameCBP CH1
-
SpeciesM. musculus (mouse)
-
Entrez GeneCrebbp (a.k.a. CBP, CBP/p300, KAT3A, p300/CBP)
- Promoter T7
Cloning Information for Gene/Insert 2
- Cloning method Restriction Enzyme
- 5′ cloning site NcoI (not destroyed)
- 3′ cloning site HindIII (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer T7 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
HisGB1-CITED2(216-269)+CBPTAZ1(340-439) was a gift from Peter Wright (Addgene plasmid # 173761 ; http://n2t.net/addgene:173761 ; RRID:Addgene_173761) -
For your References section:
Hypersensitive termination of the hypoxic response by a disordered protein switch. Berlow RB, Dyson HJ, Wright PE. Nature. 2017 Mar 16;543(7645):447-451. doi: 10.1038/nature21705. Epub 2017 Mar 8. 10.1038/nature21705 PubMed 28273070